FengE Li
Impact in
- Periodontics top 1%
- Oral microbiology and periodontitis research
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 2
- Immunology 10
- Immunotherapy and Immune Responses 9
- Co-authors
- Gregory A. Lizee (7 shared papers)Jennifer L. Krauss (2 shared papers)George Hajishengallis (2 shared papers)Jason Roszik (1 shared paper)Lorenz Christian Hofbauer (1 shared paper)Shuang Liang (1 shared paper)Jindrǐch Chmelař (1 shared paper)Ravi Jotwani (1 shared paper)
- Journals
- Frontiers in Medicine (2 papers)Vaccines (2 papers)Nature Communications (2 papers)Frontiers in Neural Circuits (1 paper)International Journal of Oncology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
FengE Li
36 papers receiving 1.3k citations
FengE Li's Hit Papers
Peers
Comparison fields: 5 of 77
- Periodontics 339
- Immunology 282
- Oncology 276
- Immunology and Allergy 29
- Cancer Research 68
Countries citing papers authored by FengE Li
This map shows the geographic impact of FengE Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by FengE Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites FengE Li more than expected).
Fields of papers citing papers by FengE Li
This network shows the impact of papers produced by FengE Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by FengE Li. The network helps show where FengE Li may publish in the future.
Co-authors
The 25 scholars most cited alongside FengE Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss Hit paper breakdown → | 2012 | 373 |
| 2 | 2010 | 158 | |
| 3 | 2015 | 136 | |
| 4 | 2021 | 96 | |
| 5 | 2015 | 85 | |
| 6 | 2021 | 64 | |
| 7 | 2015 | 41 | |
| 8 | 2021 | 38 | |
| 9 | 2020 | 31 | |
| 10 | 2014 | 30 | |
| 11 | 2016 | 27 | |
| 12 | 2017 | 27 | |
| 13 | 2024 | 22 | |
| 14 | 2020 | 17 | |
| 15 | 2023 | 17 | |
| 16 | 2018 | 16 | |
| 17 | 2015 | 15 | |
| 18 | 2020 | 15 | |
| 19 | 2011 | 11 | |
| 20 | 2008 | 10 |
About FengE Li
FengE Li is a scholar working on Oncology, Immunology, Molecular Biology, Periodontics and Hepatology, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Genetic and phenotypic traits in livestock (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), CAR-T cell therapy research (2 papers), Retinal Development and Disorders (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Periodontics (339 citations), Immunology (282 citations), Oncology (276 citations), Immunology and Allergy (29 citations) and Cancer Research (68 citations). FengE Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Gregory A. Lizee, Jennifer L. Krauss, George Hajishengallis, Jason Roszik, Lorenz Christian Hofbauer, Shuang Liang, Jindrǐch Chmelař, Ravi Jotwani, Martina Rauner and Kyoung‐Jin Chung. Their work appears in journals such as Frontiers in Medicine, Vaccines, Nature Communications, Frontiers in Neural Circuits and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.